BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32468709)

  • 1. Prognostic role of extracellular vesicles in squamous cell carcinoma of the lung.
    An HJ; Kim MH; Kim SH; Lee GW; Song DH
    Thorac Cancer; 2020 Jul; 11(7):1989-1995. PubMed ID: 32468709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of Rab27A and Rab27B expression in patients with non-small cell lung carcinoma.
    Koh HM; Song DH
    Thorac Cancer; 2019 Feb; 10(2):143-149. PubMed ID: 30480360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling protein signature predicts clinical outcome of non-small-cell lung cancer.
    Jin BF; Yang F; Ying XM; Gong L; Hu SF; Zhao Q; Liao YD; Chen KZ; Li T; Tai YH; Cao Y; Li X; Huang Y; Zhan XY; Qin XH; Wu J; Chen S; Guo SS; Zhang YC; Chen J; Shen DH; Sun KK; Chen L; Li WH; Li AL; Wang N; Xia Q; Wang J; Zhou T
    BMC Cancer; 2018 Mar; 18(1):259. PubMed ID: 29510676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of CD63 expressionin patients with non-small cell lung cancer.
    Koh H; An H; Jung J; Song D
    Pol J Pathol; 2019; 70(3):183-188. PubMed ID: 31820861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
    Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
    J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of microRNA-21 in extracellular vesicles of pleural lavage fluid of lung adenocarcinoma and its functions inducing the mesothelial to mesenchymal transition.
    Watabe S; Kikuchi Y; Morita S; Komura D; Numakura S; Kumagai-Togashi A; Watanabe M; Matsutani N; Kawamura M; Yasuda M; Uozaki H
    Cancer Med; 2020 Apr; 9(8):2879-2890. PubMed ID: 32091667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of Albumin-Globulin Score in Patients with Operable Non-Small-Cell Lung Cancer.
    Li X; Qin S; Sun X; Liu D; Zhang B; Xiao G; Ren H
    Ann Surg Oncol; 2018 Nov; 25(12):3647-3659. PubMed ID: 30229416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer.
    Igawa S; Sato Y; Ryuge S; Ichinoe M; Katono K; Hiyoshi Y; Otani S; Nagashio R; Nakashima H; Katagiri M; Sasaki J; Murakumo Y; Satoh Y; Masuda N
    Oncology; 2017; 92(5):283-290. PubMed ID: 28222447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Polymorphisms in Activating Transcription Factor 3 Binding Site and the Prognosis of Early-Stage Non-Small Cell Lung Cancer.
    Kang HG; Park JE; Lee SY; Choi JE; Do SK; Hong MJ; Lee JH; Jeong JY; Do YW; Lee EB; Shin KM; Lee WK; Choi SH; Lee YH; Seo HW; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
    Oncology; 2021; 99(5):336-344. PubMed ID: 33626541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of CD151 overexpression in non-small cell lung cancer.
    Kwon MJ; Seo J; Kim YJ; Kwon MJ; Choi JY; Kim TE; Lee DH; Park S; Shin YK; Han J; Choi YL
    Lung Cancer; 2013 Jul; 81(1):109-16. PubMed ID: 23570797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of PD-L1 protein as a prognostic factor in lung squamous cell carcinoma.
    Takada K; Okamoto T; Toyokawa G; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Oda Y; Maehara Y
    Lung Cancer; 2017 Feb; 104():7-15. PubMed ID: 28213003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.
    Anton RC; Coffey DM; Gondo MM; Stephenson MA; Brown RW; Cagle PT
    Mod Pathol; 2000 Nov; 13(11):1167-72. PubMed ID: 11106072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse Cohorts.
    Noro R; Ishigame T; Walsh N; Shiraishi K; Robles AI; Ryan BM; Schetter AJ; Bowman ED; Welsh JA; Seike M; Gemma A; Skaug V; Mollerup S; Haugen A; Yokota J; Kohno T; Harris CC
    J Thorac Oncol; 2017 Jan; 12(1):65-76. PubMed ID: 27613525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cofilin‑1 and Twist‑1 protein expression in human non‑small cell lung cancer tissues.
    Chang CY; Chang SL; Leu JD; Chang YC; Hsiao M; Lin LT; Lin HN; Lee YJ
    Oncol Rep; 2019 Aug; 42(2):805-816. PubMed ID: 31233187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of tumor markers, NSE, CA125 and SCC, in operable NSCLC Patients.
    Yu D; Du K; Liu T; Chen G
    Int J Mol Sci; 2013 May; 14(6):11145-56. PubMed ID: 23712355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer].
    Wang DF; Zeng CG; Lin YB; Hou JH; Zhu ZH
    Ai Zheng; 2006 Mar; 25(3):359-62. PubMed ID: 16536995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
    Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
    Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of DR5 and c‑FLIP proteins as novel prognostic biomarkers for non‑small cell lung cancer patients treated with surgical resection and chemotherapy.
    Zheng H; Zhang Y; Zhan Y; Liu S; Lu J; Wen Q; Fan S
    Oncol Rep; 2019 Dec; 42(6):2363-2370. PubMed ID: 31638235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.